American Journal of Cardiology
Volume 103, Issue 12 , Pages 1657-1662 , 15 June 2009

Impact of the Definition Utilized on the Rate of Contrast-Induced Nephropathy in Percutaneous Coronary Intervention

  • Refat Jabara, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • Corresponding Author InformationCorresponding author: Tel: 678-862-4789; fax: 404-843-6051
    • ,
  • Radhika R. Gadesam, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • ,
  • Lakshmana K. Pendyala, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • ,
  • William D. Knopf, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • ,
  • Nicolas Chronos, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • ,
  • Jack P. Chen, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • ,
  • Kevin Viel, PhD

      Affiliations

    • Department of Epidemiology, Emory University School of Medicine, Atlanta, Georgia
    • ,
  • Spencer B. King III, MD

      Affiliations

    • Saint Joseph's Cardiovascular Research Institute/Saint Joseph's Hospital of Atlanta, Atlanta, Georgia
    • ,
  • Steven V. Manoukian, MD

      Affiliations

    • Sarah Cannon Research Institute and Centennial Heart Center, Nashville, Tennessee

Received 18 December 2008 ,Revised 5 February 2009 ,Accepted 5 February 2009.

References 

  1. McIntosh CL, Reed R. Ioxilan injection (An overview and results of aortofemoral arteriography study). Invest Radiol. 1994;29(suppl):S40–S42
  2. Roth R, Akin M, Deligonul U, Kern MJ. Influence of radiographic contrast media viscosity to flow through coronary angiographic catheters. Cathet Cardiovasc Diagn. 1991;22:290–294
  3. Johnson C, Levey AS, Coresh J, Levin A, Lau J, Eknoyan G. Clinical practice guidelines for chronic kidney disease in adults: part II: glomerular filtration rate, proteinuria, and other markers. Am Fam Phys. 2004;70:1091–1097
  4. World Health Organization. Nutritional Anemias: Report of a WHO Scientific Group. WHO Technical Report Series 405. In: Geneva, Switzerland: World Health Organization; 1968;p. 1–37
  5. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation. 2002;105:2259–2264
  6. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368–375
  7. Harjai KJ, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol. 2008;101:812–819
  8. Barrett BJ, Parfrey PS. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354:379–386
  9. Mehran R. ICON—a prospective, randomized, placebo-controlled trial of ioxaglate vs. iodixanol in patients at increased risk for contrast nephropathy. Presented at Transcatheter Cardiovascular Therapeutics; October 25, 2006; Washington, DC.
  10. Solomon RJ, Natarajan MK, Doucet S, Sharma SK, Staniloae CS, Katholi RE, et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation. 2007;115:3189–3196
  11. Voeltz MD, Nelson MA, McDaniel MC, Manoukian SV. The important properties of contrast media: focus on viscosity. J Invasive Cardiol. 2007;19(suppl):1A–9A
  12. Weisbord SD, Hartwig KC, Sonel AF, Fine MJ, Palevsky P. The incidence of clinically significant contrast-induced nephropathy following non-emergent coronary angiography. Catheter Cardiovasc Interv. 2008;71:879–885
  13. Nicot GS, Merle LJ, Charmes JP, Valette JP, Nouaille YD, Lachâtre GF, et al. Transient glomerular proteinuria, enzymuria, and nephrotoxic reaction induced by radiocontrast media. JAMA. 1984;252:2432–2434
  14. Rickli H, Benou K, Ammann P, Fehr T, Brunner-La Rocca HP, Petridis H, et al. Time course of serial cystatin C levels in comparison with serum creatinine after application of radiocontrast media. Clin Nephrol. 2004;61:98–102
  15. Bachorzewska-Gajewska H, Malyszko J, Sitniewska E, Malyszko JS, Dobrzycki S. Neutrophil-gelatinase–associated lipocalin and renal function after percutaneous coronary interventions. Am J Nephrol. 2006;26:287–292
  16. Porter GA. Contrast-associated nephropathy. Am J Cardiol. 1989;64(suppl):22E–26E
  17. Guitterez NV, Diaz A, Timmis GC, et al. Determinants of serum creatinine trajectory in acute contrast nephropathy. J Interv Cardiol. 2002;15:349–354
  18. Morcos SK. Contrast media-induced nephrotoxicity—questions and answers. Br J Radiol. 1998;71:357–365

PII: S0002-9149(09)00591-8

doi: 10.1016/j.amjcard.2009.02.039

American Journal of Cardiology
Volume 103, Issue 12 , Pages 1657-1662 , 15 June 2009

Article Tools

* Image Usage & Resolution